Assignee
MEDIPOST CO LTD
KR·9 granted patents·13 pending applications·24 citations·filing 2002–2022
Top patents by PatentIndex Score
22 records- 0183US7459307B2Composition for treatment of articular cartilage damageMEDIPOST CO LTD·Filed 2002·Granted Dec 2, 2008·24 cites·33 claims
- 0269US11332715B2Method for culturing mesenchymal stem cellsMEDIPOST CO LTD·Filed 2019·Granted May 17, 2022·0 cites·8 claims
- 0369US2009022698A1Composition For Treatment Of Articular Cartilage DamageMEDIPOST CO LTD·Filed 2008·Application pending·0 cites
- 0469US2009047261A1Composition For Treatment Of Articular Cartilage DamageMEDIPOST CO LTD·Filed 2008·Application pending·0 cites
- 0559US2009060885A1Composition For Treatment of Articular Cartilage DamageMEDIPOST CO LTD·Filed 2008·Application pending·0 cites
- 0659US2021220256A1Hair growth promoting capacity of conditioned media of stimulated stem cells and use thereofMEDIPOST CO LTD·Filed 2021·Application pending·0 cites
- 0757US9580687B2Method for culturing mesenchymal stem cellsMEDIPOST CO LTD·Filed 2013·Granted Feb 28, 2017·0 cites·8 claims
- 0857US2010184218A1Isolation and Culture-Expansion Methods of Mesenchymal Stem/Progenitor Cells From Umbilical Cord Blood, And Differentiation Method of Umbilical Cord Blood-Derived Meschymal Stem/Progenitor Cells Into Various Mesenchymal TissuesMEDIPOST CO LTD·Filed 2009·Application pending·0 cites
- 0956US9408892B2Treating cartilage defect with UCB-MSC expressing TSP-2MEDIPOST CO LTD·Filed 2013·Granted Aug 9, 2016·0 cites·1 claims
- 1055US2025073273A1Pharmaceutical composition for prevention or treatment of inflammatory disease or pain, comprising mesenchymal stem cells expressing ptx-3, timp1 and bdnf as active ingredientMEDIPOST CO LTD·Filed 2021·Application pending·0 cites
- 1154US10294456B2Method for culturing mesenchymal stem cellsMEDIPOST CO LTD·Filed 2017·Granted May 21, 2019·0 cites·9 claims
- 1252US2018008531A1Capability of small-sized stem cells to stimulate hair growth and use thereofMEDIPOST CO LTD·Filed 2017·Application pending·0 cites
- 1351US2013189189A1COMPOSITION FOR THE DIAGNOSIS, PREVENTION OR TREATMENT OF DISEASES RELATED TO CELLS EXPRESSING IL-8 OR GRO-ALPHA, COMPRISING UCB-MSCsMEDIPOST CO LTD·Filed 2012·Application pending·0 cites
- 1451US2025017975A1Composition for preventing or treating lung diseases containing cd47-overexpressing mesenchymal stem cellsMEDIPOST CO LTD·Filed 2022·Application pending·0 cites
- 1550US2007178073A1Composition Comprising Separated or Proliferated Cells from Umbilical Cord Blood for Treating Developmental and/or Chronic Lung DiseaseMEDIPOST CO LTD·Filed 2006·Application pending·0 cites
- 1649US10150950B2Method for culturing mesenchymal stem cells according to cell sizeMEDIPOST CO LTD·Filed 2014·Granted Dec 11, 2018·0 cites·11 claims
- 1749US9439931B2Administering umbilical cord blood-derived mesenchymal stem cells to treat nerve injuryMEDIPOST CO LTD·Filed 2013·Granted Sep 13, 2016·0 cites·2 claims
- 1846US10307442B2Pharmaceutical composition for the prevention or treatment of a pulmonary disorder comprising mesenchymal stem cells having improved proliferation and differentiation capacityMEDIPOST CO LTD·Filed 2016·Granted Jun 4, 2019·0 cites·15 claims
- 1945US2016000698A1Capability of small-sized stem cells to stimulate hair growth and use thereofMEDIPOST CO LTD·Filed 2015·Application pending·0 cites
- 2043US12303534B2Pharmaceutical composition comprising mesenchymal stem cells as effective ingredient for prevention or treatment of inflammatory diseaseMEDIPOST CO LTD·Filed 2019·Granted May 20, 2025·0 cites·8 claims
- 2138US2006024825A1Method of promoting expansion of stem cellsMEDIPOST CO LTD·Filed 2005·Application pending·0 cites
- 2237US2016000699A1Hair growth promoting capacity of conditioned media of stimulated stem cells and use thereofMEDIPOST CO LTD·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →